Disse B, Gundert-Remy U, Weber E, Andrassy K, Sietzen W, Lang A
Int J Clin Pharmacol Ther Toxicol. 1986 Sep;24(9):460-4.
The kinetics of erythromycin (E.) was studied in 16 patients with different degrees of impairment of renal function after a single intravenous dose. Renal clearance of E. was found to be significantly correlated to the creatinine clearance. Total recovery in urine did not exceed 7.5%. As expected from the small fraction excreted via the kidneys, the elimination half-life and the total clearance of E. did not depend on renal function. We conclude that impairment of renal function does not justify a dose adjustment of E. Hearing acuity should, however, be monitored during treatment since transient deafness predominantly in patients with renal failure has been reported by various authors.
对16例肾功能不同程度受损的患者单次静脉注射红霉素后,研究了其动力学。发现红霉素的肾清除率与肌酐清除率显著相关。尿液中的总回收率不超过7.5%。正如从经肾脏排泄的小部分药物所预期的那样,红霉素的消除半衰期和总清除率不依赖于肾功能。我们得出结论,肾功能受损并不能成为调整红霉素剂量的理由。然而,治疗期间应监测听力,因为已有多位作者报道主要在肾衰竭患者中出现短暂性耳聋。